B

Beijing Airdoc Technology Co Ltd
HKEX:2251

Watchlist Manager
Beijing Airdoc Technology Co Ltd
HKEX:2251
Watchlist
Price: 12.1 HKD 1.17%
Market Cap: 1.3B HKD
Have any thoughts about
Beijing Airdoc Technology Co Ltd?
Write Note

Beijing Airdoc Technology Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Airdoc Technology Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Airdoc Technology Co Ltd
HKEX:2251
Accrued Liabilities
ÂĄ55m
CAGR 3-Years
98%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Accrued Liabilities
ÂĄ213.1m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Medlive Technology Co Ltd
HKEX:2192
Accrued Liabilities
ÂĄ65.8m
CAGR 3-Years
44%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Accrued Liabilities
ÂĄ33.9m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
20%
B-SOFT Co Ltd
SZSE:300451
Accrued Liabilities
ÂĄ190.1m
CAGR 3-Years
143%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Accrued Liabilities
ÂĄ441.4m
CAGR 3-Years
152%
CAGR 5-Years
88%
CAGR 10-Years
69%
No Stocks Found

Beijing Airdoc Technology Co Ltd
Glance View

Market Cap
1.3B HKD
Industry
Health Care

Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. The company is headquartered in Beijing, Beijing and currently employs 369 full-time employees. The company went IPO on 2021-11-05. The firm's main product is Airdoc-AIFUNDUS 1.0. The firm's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.

Intrinsic Value
19.61 HKD
Undervaluation 38%
Intrinsic Value
Price
B

See Also

What is Beijing Airdoc Technology Co Ltd's Accrued Liabilities?
Accrued Liabilities
55m CNY

Based on the financial report for Dec 31, 2023, Beijing Airdoc Technology Co Ltd's Accrued Liabilities amounts to 55m CNY.

What is Beijing Airdoc Technology Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
98%

Over the last year, the Accrued Liabilities growth was 99%. The average annual Accrued Liabilities growth rates for Beijing Airdoc Technology Co Ltd have been 98% over the past three years .

Back to Top